Dr. Ansuman Satpathy M.D., Ph.D. in the Department of Pathology at Stanford University School of Medicine. He is a member of the Stanford Cancer Institute, the Parker Institute for Cancer Immunotherapy, the Immunology, Cancer Biology, and Biomedical Informatics Programs, Bio-X, and a faculty fellow in ChEM-H. Dr. Satpathy completed an M.D. and Ph.D. in immunology at Washington University in St. Louis, clinical residency in pathology at Stanford Hospital and Clinics, and postdoctoral training in genetics at Stanford University. Dr. Satpathy’s research group focuses on developing and applying genome-scale technologies to study fundamental properties of the immune system in health, infection, and cancer.
The future of drug development is likely to be deeply impacted by machine learning in a multitude of ways. This panel will reflect on the past, present, and future of what has made drug discovery flourish and fail; with a special focus on the technology driving cutting-edge precision medicine.